Sfoglia per Autore
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION
2014-01-01 Teti, ANNA MARIA; Rucci, Nadia; Maurizi, Antonio; Capulli, Mattia
SMALL INTERFERING RNA (siRNA) PER LA TERAPIA DELL’OSTEOPETROSI AUTOSOMICA DOMINANTE DI TIPO 2 (ADO2) CAUSATA DA MUTAZIONE DEL GENE CLCN7 (ADO2 CLCN7-DIPENDENTE)
2014-01-01 Teti, ANNA MARIA; Capulli, M; Rucci, M; Maurizi, A.
The Great Beauty of the osteoclast
2014-01-01 Cappariello, A; Maurizi, A; Veeriah, V; Teti, ANNA MARIA
Reprint of: The Great Beauty of the osteoclast
2014-01-01 Cappariello, A.; Maurizi, A.; Veeriah, V.; Teti, A.
Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models
2014-01-01 Alam, I; Gray, Ak; Chu, K; Ichikawa, S; Mohammad, Ks; Capannolo, M; Capulli, Mattia; Maurizi, A; Muraca, M; Teti, ANNA MARIA; Econs, Mj; Del Fattore, A.
Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) Autosomal Dominant Oosteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation
2015-01-01 Teti, ANNA MARIA; Rucci, Nadia; Capulli, Mattia; Maurizi, Antonio
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation
2015-01-01 Cappariello, Alfredo; Paone, Riccardo; Maurizi, Antonio; Capulli, Mattia; Rucci, Nadia; Muraca, Maurizio; Teti, ANNA MARIA
Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation
2015-01-01 Wei, J.; Shimazu, J.; Makinistoglu, M. P.; Maurizi, A.; Kajimura, D.; Zong, H.; Takarada, T.; Lezaki, T.; Pessin, J. E.; Hinoi, E.; Karsenty, G.
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2
2015-01-01 Capulli, Mattia; Maurizi, Antonio; Ventura, Luca; Rucci, Nadia; Teti, ANNA MARIA
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate
2016-01-01 Thaler, Roman; Maurizi, Antonio; Roschger, Paul; Sturmlechner, Ines; Khani, Farzaneh; Spitzer, Silvia; Rumpler, Monika; Zwerina, Jochen; Karlic, Heidrun; Dudakovic, Amel; Klaushofer, Klaus; Teti, ANNA MARIA; Rucci, Nadia; Varga, Franz; Van Wijnen, Andre J.
MC4R-dependent suppression of appetite by bone-derived lipocalin 2
2017-01-01 Mosialou, I.; Shikhel, S.; Liu, J. -M.; Maurizi, A.; Luo, N.; He, Z.; Huang, Y.; Zong, H.; Friedman, R. A.; Barasch, J.; Lanzano, P.; Deng, L.; Leibel, R. L.; Rubin, M.; Nicholas, T.; Chung, W.; Zeltser, L. M.; Williams, K. W.; Pessin, J. E.; Kousteni, S.
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM
2018-01-01 Capulli, Mattia; Ponzetti, Marco; Maurizi, Antonio; GEMINI PIPERNI, Sara; Berger, Thorsten; Mak, Tak Wah; Teti, Anna; Rucci, Nadia
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone
2018-01-01 Cappariello, Alfredo; Loftus, Alexander; Muraca, Maurizio; Maurizi, Antonio; Rucci, Nadia; Teti, Anna
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate
2018-01-01 Thaler, R.; Maurizi, A.; Roschger, P.; Sturmlechner, I.; Khani, F.; Spitzer, S.; Wijnen, A. J.
The osteoclast in bone metastasis: Player and target
2018-01-01 Maurizi, A.; Rucci, N.
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development
2018-01-01 Maurizi, Antonio; Capulli, Mattia; Patel, Rajvi; Curle, Annabel; Rucci, Nadia; Teti, ANNA MARIA
Effect of rapamycin on bone mass and strength in the α2(I)-G610C mouse model of osteogenesis imperfecta
2019-01-01 Bateman, J. F.; Sampurno, L.; Maurizi, A.; Lamande, S. R.; Sims, N. A.; Cheng, T. L.; Schindeler, A.; Little, D. G.
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry
2019-01-01 Capulli, M.; Hristova, D.; Valbret, Z.; Carys, K.; Arjan, R.; Maurizi, A.; Masedu, F.; Cappariello, A.; Rucci, N.; Teti, A.
Osteopetrosis
2019-01-01 Maurizi, A.; Teti, A.
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications
2019-01-01 Maurizi, A.; Capulli, M.; Curle, A.; Patel, R.; Ucci, A.; Cortes, J. A.; Oxford, H.; Lamande, S. R.; Bateman, J. F.; Rucci, N.; Teti, A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION | 1-gen-2014 | Teti, ANNA MARIA; Rucci, Nadia; Maurizi, Antonio; Capulli, Mattia | |
SMALL INTERFERING RNA (siRNA) PER LA TERAPIA DELL’OSTEOPETROSI AUTOSOMICA DOMINANTE DI TIPO 2 (ADO2) CAUSATA DA MUTAZIONE DEL GENE CLCN7 (ADO2 CLCN7-DIPENDENTE) | 1-gen-2014 | Teti, ANNA MARIA; Capulli, M; Rucci, M; Maurizi, A. | |
The Great Beauty of the osteoclast | 1-gen-2014 | Cappariello, A; Maurizi, A; Veeriah, V; Teti, ANNA MARIA | |
Reprint of: The Great Beauty of the osteoclast | 1-gen-2014 | Cappariello, A.; Maurizi, A.; Veeriah, V.; Teti, A. | |
Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models | 1-gen-2014 | Alam, I; Gray, Ak; Chu, K; Ichikawa, S; Mohammad, Ks; Capannolo, M; Capulli, Mattia; Maurizi, A; Muraca, M; Teti, ANNA MARIA; Econs, Mj; Del Fattore, A. | |
Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) Autosomal Dominant Oosteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation | 1-gen-2015 | Teti, ANNA MARIA; Rucci, Nadia; Capulli, Mattia; Maurizi, Antonio | |
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation | 1-gen-2015 | Cappariello, Alfredo; Paone, Riccardo; Maurizi, Antonio; Capulli, Mattia; Rucci, Nadia; Muraca, Maurizio; Teti, ANNA MARIA | |
Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation | 1-gen-2015 | Wei, J.; Shimazu, J.; Makinistoglu, M. P.; Maurizi, A.; Kajimura, D.; Zong, H.; Takarada, T.; Lezaki, T.; Pessin, J. E.; Hinoi, E.; Karsenty, G. | |
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 | 1-gen-2015 | Capulli, Mattia; Maurizi, Antonio; Ventura, Luca; Rucci, Nadia; Teti, ANNA MARIA | |
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate | 1-gen-2016 | Thaler, Roman; Maurizi, Antonio; Roschger, Paul; Sturmlechner, Ines; Khani, Farzaneh; Spitzer, Silvia; Rumpler, Monika; Zwerina, Jochen; Karlic, Heidrun; Dudakovic, Amel; Klaushofer, Klaus; Teti, ANNA MARIA; Rucci, Nadia; Varga, Franz; Van Wijnen, Andre J. | |
MC4R-dependent suppression of appetite by bone-derived lipocalin 2 | 1-gen-2017 | Mosialou, I.; Shikhel, S.; Liu, J. -M.; Maurizi, A.; Luo, N.; He, Z.; Huang, Y.; Zong, H.; Friedman, R. A.; Barasch, J.; Lanzano, P.; Deng, L.; Leibel, R. L.; Rubin, M.; Nicholas, T.; Chung, W.; Zeltser, L. M.; Williams, K. W.; Pessin, J. E.; Kousteni, S. | |
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM | 1-gen-2018 | Capulli, Mattia; Ponzetti, Marco; Maurizi, Antonio; GEMINI PIPERNI, Sara; Berger, Thorsten; Mak, Tak Wah; Teti, Anna; Rucci, Nadia | |
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone | 1-gen-2018 | Cappariello, Alfredo; Loftus, Alexander; Muraca, Maurizio; Maurizi, Antonio; Rucci, Nadia; Teti, Anna | |
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate | 1-gen-2018 | Thaler, R.; Maurizi, A.; Roschger, P.; Sturmlechner, I.; Khani, F.; Spitzer, S.; Wijnen, A. J. | |
The osteoclast in bone metastasis: Player and target | 1-gen-2018 | Maurizi, A.; Rucci, N. | |
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development | 1-gen-2018 | Maurizi, Antonio; Capulli, Mattia; Patel, Rajvi; Curle, Annabel; Rucci, Nadia; Teti, ANNA MARIA | |
Effect of rapamycin on bone mass and strength in the α2(I)-G610C mouse model of osteogenesis imperfecta | 1-gen-2019 | Bateman, J. F.; Sampurno, L.; Maurizi, A.; Lamande, S. R.; Sims, N. A.; Cheng, T. L.; Schindeler, A.; Little, D. G. | |
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry | 1-gen-2019 | Capulli, M.; Hristova, D.; Valbret, Z.; Carys, K.; Arjan, R.; Maurizi, A.; Masedu, F.; Cappariello, A.; Rucci, N.; Teti, A. | |
Osteopetrosis | 1-gen-2019 | Maurizi, A.; Teti, A. | |
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications | 1-gen-2019 | Maurizi, A.; Capulli, M.; Curle, A.; Patel, R.; Ucci, A.; Cortes, J. A.; Oxford, H.; Lamande, S. R.; Bateman, J. F.; Rucci, N.; Teti, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile